PCSK9 variation and association with blood pressure in African Americans: preliminary findings from the HyperGEN and REGARDS studies

Proprotein convertase subtilisin/kexin type 9 (encoded by PCSK9) plays a well-known role in the regulation of low-density lipoprotein (LDL) receptors, and an inhibitor of this enzyme is a promising new therapeutic for hyperlipidemia. Recently, animal and human studies also implicate PCSK9 genetic va...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Ngan T Tran, Stella eAslibekyan, Hemant K Tiwari, Degui eZhi, Yun Ju Sung, DC eRao, Steven C. Hunt, Ulrich eBroeckel, Donna K Arnett, Suzanne E Judd, Paul eMuntner, Shia T Kent, Ryan eIrvin
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Frontiers Media S.A. 2015-04-01
Цуврал:	Frontiers in Genetics
Нөхцлүүд:	Blood Pressure Hypertension Dyslipidemia pcsk9 Low-density lipoprotein cholesterol
Онлайн хандалт:	http://journal.frontiersin.org/Journal/10.3389/fgene.2015.00136/full
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!